The basophil proteome in chronic spontaneous urticaria distinguishes responders to omalizumab from non-responders.
Stitt JM, Dzieciatkowska M, Edwards MG, Hansen K, Hedlund G, Dreskin SC. The basophil proteome in chronic spontaneous urticaria distinguishes responders to omalizumab from non-responders. Clin Exp Allergy. 2018 07; 48(7):898-901.